This activity aims to advance knowledge in precision medicine and genetics, particularly within ophthalmology, by highlighting emerging technologies including artificial intelligence, stem cell research, and gene-based therapies. This program will equip clinicians and researchers with the knowledge needed to advance patient care and treatment outcomes in the rapidly evolving field of ophthalmic precision medicine.

ACCREDITATION STATEMENT
The Columbia University Vagelos College of Physicians and Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT 
The Columbia University Vagelos College of Physicians and Surgeons designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.